4//SEC Filing
Tan Meng Dong (James) 4
Accession 0001493152-22-033757
CIK 0001847846other
Filed
Nov 24, 7:00 PM ET
Accepted
Nov 25, 9:57 PM ET
Size
14.5 KB
Accession
0001493152-22-033757
Insider Transaction Report
Form 4
Tan Meng Dong
DirectorChief Executive Officer10% Owner
Transactions
- Purchase
Ordinary Shares
2021-11-24+292,250→ 292,250 total - Purchase
Rights
2021-11-24+292,250→ 292,250 total→ Ordinary shares (29,225 underlying) - Other
Ordinary Shares
2022-11-17+2,776,000→ 2,776,000 total - Other
Ordinary Shares
2021-11-24+3,000→ 3,000 total - Purchase
Warrants
2021-11-24+292,250→ 292,250 totalExercise: $11.50→ Ordinary shares (146,125 underlying)
Holdings
- 2,141,250(indirect: See Footnote)
Ordinary Shares
Footnotes (7)
- [F1]The securities reported here were received from Mr. Tan's through his redemption of 8i Capital Limited's and 8i Enterprises Pte Ltd.'s holdings in Watermark Developments Limited at the closing of EUDA Health Holdings Limited's business combination with EUDA Health Limited. The total capital contribution that Mr. Tan invested was $400,000 prior to redemption.
- [F2]The securities reported herein are held by 8i Holdings 2 Pte. Ltd. and may be deemed to be indirectly beneficially owned by Mr. Meng Dong (James) Tan. Mr. Tan disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein, and this report shall not be deemed an admission that such person is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.
- [F3]The shares were transferred to Mr. Meng Dong (James) Tan from 8i Holdings 2 Pte. Ltd.
- [F4]The reporting person acquired 292,250 units consisting of ordinary shares, warrants and rights at a purchase price of $10.00 per share.
- [F5]The warrants become exercisable on the later of (i) the completion of the registrant's initial business combination and (ii) 12 months from the closing of the registrant's initial public offering.
- [F6]The warrants expire 5 years after the completion of the registrant's initial business combination or earlier upon redemption or liquidation, as described in the registrant's prospectus filed with the SEC.
- [F7]The rights convert automatically into ordinary shares at the completion of the registrant's initial business combination.
Documents
Issuer
EUDA Health Holdings Ltd
CIK 0001847846
Entity typeother
Related Parties
1- filerCIK 0001653051
Filing Metadata
- Form type
- 4
- Filed
- Nov 24, 7:00 PM ET
- Accepted
- Nov 25, 9:57 PM ET
- Size
- 14.5 KB